Mark Newcomer
President and Chief Executive Officer
Replay available
Paysign, Inc. (NASDAQ: PAYS) Q2 2026 earnings conference call, held 2026-08-05. Replay captured from the company's public earnings webcast.

President and Chief Executive Officer
Chief Financial Officer
President of Patient Affordability
Chief Payments Officer
Analyst at Barrington Research
Analyst at Lake Street Capital Markets
Analyst at D.A. Davidson
Analyst at Vandenberg Thalma
Good afternoon, my name is Kevin and I'll be your conference operator today. At this time, I'd like to welcome everyone to PaySign, Inc.'s second quarter 2026 earnings conference call. After the speaker's remarks, there will be a question and answer session. If you'd like to be placed into question queue, please press star 1 on your telephone keypad. As a reminder, this conference call is being recorded. The comments on today's call regarding PaySign's financial results will be on a gap basis unless otherwise noted. PaySign's earnings release was disseminated to the SEC earlier today and can be found on the investor relations section of our website, PaySign.com, which includes reconciliations of non-GAAP measures to GAAP reported amounts. Additionally, as set forth in more detail in our earnings release, I'd like to remind everyone that today's call will include forward-looking statements regarding PaySign's future performance. Actual performance could differ materially from these forward-looking statements. Information about the factors that could affect future performance is summarized at the end of Paysign's earnings release and in our recent SEC filings. Lastly, a replay of the call will be available until November 4, 2026. Please see Paysign's second quarter 2026 earnings call announcement for details on how to access the replay. It is now my pleasure to turn the call over to Mr. Mark Newcomer, President and CEO. Please go ahead. Thank you, Kevin, and good afternoon, everyone. Thank you for joining us for Paysign's second quarter 2026 earnings call. I'm Mark Newcomer, President and Chief Executive Officer, and I'm joined today by Jeff Baker, our Chief Financial Officer. Also with us are Matt Turner, our President of Patient Affordability, and Matt Lanford, our C...